Flatiron Health is a New York,United States based AI Healthcare tech company that enables cancer researchers & providers to learn from the experience of every patient.( i.e AI in Oncology)

Flatiron’s vision is to build a connected technology platform that enables the development of actionable insights that can help cancer researchers and care providers learn from every patient’s experience.

To serve cancer patients and our customers by dramatically improving treatment and accelerating research.

Nat Turner and Zach Weinberg founded Flatiron Health in 2012 shortly after their first company was acquired by Google.

Quick Facts:

• Two million active patient records available for research by Flatiron's solutions

• Flatiron's OCM network includes 55 community oncology practices across 20 states

• 265+ community oncology clinics

• 2,500+ OncoEMR clinician users

• 13 out of the top 14 therapeutic oncology companies work with Flatiron

• $328+ million in funding

• 450 employees

• Headquarters in NYC, office in SF

• Funding from investors Allen & Company, Baillie Gifford & Co., Casdin Capital, Google Ventures, Roche Venture Fund

Flatiron Products:

Stay ahead with the most efficient technology platform in community oncology.

BioBeats is a digital health and artificial intelligence business that creates corporate and personal wellness solutions.

BioBeats built a world-class team which includes renowned experts in the fields of artificial intelligence, machine learning, wearables including battery life optimisation, cloud solutions and theoretical computer science.

At our core, we provide insights into an individual’s health and wellbeing, by tracking data from wearable and smartphone sensors. 

Products:

Hear And Now

OrCam harnesses the power of Artificial Vision in an intuitive portable device that compensates for lost visual abilities.OrCam MyEye 2.0 is all about using technology to help blind and visually impaired people achieve increased independence.

OrCam’s mission is to harness the power of artificial vision by incorporating pioneering technology into a wearable platform which improves the lives of individuals who are blind, visually impaired, and have reading difficulties.

OrCam was jointly founded in 2010 by Prof. Amnon Shashua and Mr. Ziv Aviram, who are also the co-founders of Mobileye, the collision avoidance system leader and autonomous driving innovator. The original OrCam MyEye device was launched in 2015, and the next generation OrCam MyEye 2.0 was launched in 2017

Co Founder:

Prof. Amnon Shashua holds the Sachs Chair in Computer Science at the Hebrew University of Jerusalem. His field of expertise is computer vision and machine learning. For his academic achievements, he has received the Marr Prize Honorable Mention in 2001, the Kaye Innovation Award in 2004, and the Landau Award in Exact Sciences in 2005.

Mr. Aviram is one of Israel’s most esteemed managers. Before co-founding OrCam, Mr. Aviram co-founded Mobileye, an Israeli technology company that develops vision-based advanced driver-assistance systems (ADAS) providing warnings for collision prevention and mitigation. Today 90% of the world’s leading automobile manufacturers rely on Mobileye technology to make their vehicles safer to drive. 

He is the co-founder of Mobileye, an Israeli technology company that develops vision-based advanced driver-assistance systems (ADAS) providing warnings for collision prevention and mitigation.

Products:

https://www.orcam.com/en/myeye2/

We are an AI startup, building delightful products for cancer radiologists. Looking for beta users for our first product in Liver Cancer!

Predible Health, which runs an artificial intelligence-based cancer radiology platform, has raised an undisclosed amount from impact investor Unitus Seed Fund.

"Unitus’ funding will enable Predible to scale up the development of our cancer AI platform as well as invest in regulatory approvals for our existing products," said Predible Health chief executive Suthirth Vaidya. "Our clinical validation studies are displaying positive results and we are now working to bring our offerings into clinical practice."

The startup says it has processed more than two million images since its inception in 2016, and it is aiming to touch 500 million images by December 2020. It currently has tie-ups with healthcare institutions such as Tata Memorial Hospital in Mumbai, Mahajan Imaging in Delhi and Narayana Health in Bengaluru.

Predible Health facilitates cancer diagnosis through its artificial intelligence powered clinical applications for liver and lung cancers which enable radiologists to interpret images faster and with more accuracy. It has developed algorithms to help physicians characterise diseases as well as plan and deliver personalised treatment.

The company has developed two flagship products, including Predible Liver, which assists surgeons with precise planning for liver transplant and tumour resections through instant analysis and 3D visualisation of liver lesions and hepatic structures. Built on the cloud, the solution can be accessed by hospitals across India with an internet connection

Company details: